contact  |  jobs  |  site map  |  home
News > Press Releases > Press Release Archive
Date Title

2009
12/15/2009 StemCells, Inc. Strengthens Patent Position in Embryonic and Induced Pluripotent Stem Cell Technology Platforms
12/3/2009 StemCells, Inc. Welcomes Approval of First Embryonic Stem Cell Lines Under New NIH Guidelines
11/23/2009 StemCells, Inc. CEO Martin McGlynn Featured on BioBusiness.TV's "Stem Cell Review" Series
11/23/2009 StemCells, Inc. Initiates Landmark Trial Targeting "Communication Highway" of the Brain
11/18/2009 StemCells, Inc. Provides Update on NCL Program Meeting with FDA
11/5/2009 StemCells, Inc. Reports Third Quarter Financial Results
11/3/2009 StemCells, Inc. Closes $12.5 Million Equity Financing
10/28/2009 StemCells, Inc. Announces $12.5 Million Equity Financing
10/19/2009 StemCells, Inc.'s Neural Stem Cells Show Promise for Treating Age-Related Macular Degeneration
9/22/2009 StemCells, Inc. Announces Initiatives to Advance Cell-Based Technologies for Pharmaceutical Industry and Research Applications
9/21/2009 StemCells, Inc. Announces Participation In 2009 World Stem Cell Summit
9/10/2009 StemCells, Inc. To Initiate First Ever Neural Stem Cell Trial In Myelination Disorder
9/08/2009 StemCells, Inc. To Present At Two Investor Conferences In September
9/03/2009 StemCells, Inc. Demonstrates Protection Of Neurological Function In Batten Mouse
8/10/2009 StemCells, Inc. Reports Second Quarter Financial Results
6/25/2009 StemCells, Inc. to be Added to Russell 3000 Index
6/11/2009 StemCells, Inc. to Present at Jefferies Third Annual Healthcare Conference
6/08/2009 StemCells, Inc. Announces Positive Phase I Batten Trial Results
Reports Evidence of Engraftment and Long-Term Survival of HuCNS-SC® Cells
6/01/2009 StemCells, Inc. To Present Phase I Clinical Trial Results At The 12th International Congress On NCL
5/15/2009 U.S. Patent Office Upholds StemCells’ Patents – Company Moves to Resume Patent Infringement Cases Against Neuralstem
5/08/2009 StemCells Announces 2009 First Quarter Financial Results
4/29/2009 StemCells, Inc. Collaborator To Present At Association For Research In Vision And Opthamology Annual Meeting
4/16/2009 StemCells, Inc. Announces License Agreement With Major Pharmaceutical Company Covering Gene Insertion Technology
4/1/2009 StemCells, Inc. Closes its Acquisition of the Operating Assets and Businesses of Stem Cell Sciences PLC
3/16/2009 StemCells Announces Fourth Quarter And Year End 2008 Financial Results
3/2/2009 StemCells, Inc. to Acquire Cell-Based Drug Discovery Platforms and Related Businesses of Stem Cell Sciences plc
2/20/2009 StemCells, Inc. Comments On PLoS Medicine Article Concerning Cell Transplants In Russia
2/5/2009 StemCells, Inc. to Present at The 11th Annual BIO CEO & Investor Conference
1/14/2009 Dawson James Securities Initiates Research Coverage of StemCells, Inc. With Buy Recommendation

ˆTop

2008
12/18/2008 StemCells, Inc. Receives FDA Approval To Initiate Clinical Trial Of HuCNS-SC® Cells In A Myelin Disease
11/18/2008 StemCells,Inc. Closes $20 Million Equity Financing
11/14/2008 StemCells, Inc. Announces Four Presentations At Society For Neuroscience Annual Meeting
11/12/2008 StemCells, Inc. Announces $20 Million Equity Financing
11/04/2008 StemCells Announces Third Quarter 2008 Financial Results
10/30/2008 StemCells, Inc. Announces Preclinical Results Showing its Proprietary Human Neural Stem Cells Can Prevent Vision Loss
10/02/2008 StemCells, Inc. Receives NIH Grant To Pursue Cell-Based Therapeutic For Hepatitis C
8/13/2008 StemCells, Inc. Appoints Stewart Craig, Ph.D., Senior Vice President, Development and Operations
8/8/2008 StemCells, Inc. to Present on Batten Disease to the California Institute of Regenerative Medicine's Oversight Committee
8/5/2008 StemCells Announces Second Quarter Financial Results
6/25/2008 StemCells, Inc. Files Replacement Shelf Registration Statement
6/6/2008 StemCells, Inc.’s New Patent Strengthens Its Leadership in the Discovery and Use of Monoclonal Antibodies for Isolating Rare Cells
5/29/2008 StemCells Confirms Previously Reported Batten Trial Death Was Due to Natural Progression of Disease
5/12/2008 StemCells Files Second Suit Against Neuralstem to Protect Intellectual Property
5/9/2008 StemCells, Inc. Supports National Neurotechnology Initiative Act
5/6/2008 StemCells Announces 2008 First Quarter Results
4/23/2008 StemCells, Inc. Granted Key U.S. Patent Covering Composition of Neural Stem Cells Derived From Any Tissue Source, Including Embryonic
4/15/2008 U.S. Patent Office Upholds StemCells, Inc.'s Patents In Reexamination Decisions
3/14/2008 StemCells Announces 2007 Fourth Quarter And Year End Results
3/4/2008 StemCells, Inc. Terminates Its Discussions To Acquire Progenitor Cell Therapy, LLC
1/24/2008 StemCells, Inc. Enters Research Collaboration With Casey Eye Institute
1/18/2008 StemCells, Inc. Provides Batten’s Clinical Trial Update

ˆTop

2007
12/03/07 StemCells, Inc. Exploring Acquisition of Progenitor Cell Therapy, LLC
11/30/07 First Patient Completes StemCells, Inc.’s Phase I Clinical Trial
11/5/07 StemCells Announces Third Quarter 2007 Financial Results
11/1/07 StemCells, Inc. to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9/26/07 StemCells, Inc. Announces Research Collaboration Focused On Cell-Based Liver Therapy
9/20/07 StemCells, Inc. to Present at UBS Global Life Sciences Conference
9/17/07 StemCells to Begin Patent Reexamination Process with U.S. Patent and Trademark Office
7/31/07 StemCells Announces Second Quarter 2007 Financial Results
6/28/07 StemCells, Inc. Agrees to Stay Litigation Against Neuralstem Pending Reexamination of Patents Involved in Lawsuit
6/18/07 StemCells, Inc. Announces Important Milestone in Batten Disease Clinical Trial
6/5/07 StemCells, Inc. Announces Pulblication Describing Non-Invasive Tracking of Human Neural Stem Cells Transplanted In Vivo
5/7/07 StemCells Announces First Quarter 2007 Financial Results
2/28/07 StemCells Announces Fourth Quarter and Year End 2006 Financial Results
1/12/07 StemCells, Inc., Elects Desmond O'Connell to Board of Directors

ˆTop

2006
12/06/06 Investigator in Phase I Clinical Trial for Batten Disease to Present at Lysosomal Disease Network World Symposium
12/05/06 StemCells, Inc. Announces Key Executive Appointments
11/15/06 StemCells, Inc. Announces First Human Neural Stem Cell Transplant
11/01/06 StemCells Announces Third Quarter 2006 Financial Results
10/27/06 StemCells, Inc. to Present at the Rodman & Renshaw 8th Annual Healthcare Conference Conference
9/21/06 StemCells, Inc. to Present at UBS Global Life Sciences Conference
8/29/06 StemCells, Inc. Grants License to Stem Cell Therapeutics
8/1/06 StemCells Announces Second Quarter 2006 Financial Results
7/20/06 StemCells, Inc. to Present Preclinical Data Showing Engraftment of Human Liver-Derived Cells at the World Transplant Congress
7/10/06 StemCells, Inc. to Present at C. E. Unterberg, Towbin Emerging Growth Opportunities Conference
6/27/06 StemCells, Inc. to Present at the International Society for Stem Cell Research Annual Meeting
4/28/06 StemCells Announces First Quarter 2006 Financial Results
4/10/06 StemCells, Inc. Names Elizabeth Leininger Vice President, Regulatory Affairs and Quality Assurance
4/7/06 StemCells, Inc. Announces Closing of $35.8 Million Financing
4/3/06 StemCells Announces Sale of Common Stock
3/16/06 StemCells Announces Fourth Quarter and Year End 2005 Financial Results
3/09/06 StemCells, Inc. Receives IRB Approval From Oregon Health & Science University To Begin Phase I Clinical Trial In Batten Disease
3/06/06 StemCells, Inc. to Present at Cowen & Co. 26th Annual Health Care Conference
1/10/06 StemCells, Inc. Names Maria Millan, M.D., F.A.C.S., to Lead Its Liver Cell Transplant Program

ˆTop

2005
12/06/05 StemCells, Inc. to Present at Harris Nesbitt Focus on Healthcare Conference
11/15/05 StemCells, Inc. Added to NASDAQ Biotechnology Index®
11/04/05 StemCells, Inc. to Participate in Stem Cell Research Challenges Conference
11/03/05 StemCells, Inc. to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference
10/28/05 StemCellsAnnounces Third Quarter 2005 Financial Results
10/20/05 StemCells, Inc. Receives FDA Clearance to Initiate Phase I Clinical Trial of Neural Stem Cells to Treat Batten Disease
10/18/05 StemCells, Inc. to Present at BIO InvestorForum
09/30/05 StemCells, Inc. Moves to NASDAQ National Market
09/20/05 StemCells, Inc. to Present at UBS Global Life Sciences Conference
09/19/05 Published Study Shows First Direct Link Between Human Neural Stem Cells and Restored Motor Function in Spinal Cord Injured Mice
09/19/05 StemCells Files IND Amendment for Human Neural Stem Cell Transplant Treatment for Batten Disease
09/07/05 StemCells Appoints Rodney K.B. Young CFO and VP, Finance
08/31/05 StemCells Receives Manufacturing License for Cell Processing Facility in California
07/29/05 StemCells Announces Second Quarter 2005 Financial Results
07/06/05 StemCells, Inc. Grants License to ReNeuron
06/29/05 StemCells, Inc. Added to Russell 3000® Index
06/09/05 StemCells, Inc. to Present at Morgan Stanley Small Cap Executive Conference
05/02/05 StemCells Announces First Quarter 2005 Financial Results
03/31/05 StemCells, Inc. Issues FDA Update on Proposed Clinical Trial
03/04/05 StemCells Announces Fourth Quarter and Year End 2004 Financial Results
02/28/05 StemCells, Inc. Names Alan Jacobs Chief Medical Officer and Vice President of Clinical Research, Neural Program
02/01/05 StemCells, Inc. Announces Communications with FDA on Proposed Phase I Clinical Trial
01/04/05 StemCells, Inc. Announces Filing of IND for Human Neural Stem Cell Transplant Treatment for Batten Disease

ˆTop

2004
11/08/04 StemCells Appoints Judi R. Lum CFO and VP, Finance
11/04/04 StemCells Comments on Passage of California Proposition 71; Company Supports Stem Cell Research and Cures Initiative
11/04/04 CEO's interview with Bloomberg TV
High Quality (8mb)
Low Quality (3mb)
Requires Windows Media Player
11/01/04 StemCells Completes Equity Financing; $22.5 Million in Funds to Support Batten's Trial
10/26/04 StemCells Raises $22.5 Million in New Equity Financing
10/26/04 StemCells Announces Third Quarter 2004 Financial Results
10/13/04 StemCells to Present at Investment and Scientific Conference
09/20/04 StemCells Technology Furthers Research into Alzheimer's Disease and Spinal Cord Injuries
08/23/04 StemCells, Inc. Granted U.S. Patent for Human Neural Stem Cell Compositions
07/30/04 StemCells Announces Second Quarter 2004 Financial Results
07/28/04 StemCells' Human Neural Stem Cells Survive, Migrate and Differentiate in Pre- Clinical Stroke Study
06/17/04 StemCells Raises $20 Million in New Equity Financing
06/01/04 StemCells To Present at BIO 2004 International Convention
05/04/04 StemCells Announces First Quarter 2004 Financial Results
04/06/04 StemCells Announces Fourth Quarter and Year End 2003 Financial Results
03/03/04 StemCells Elects Eric H. Bjerkholt to Board of Directors
02/20/04 StemCells, Inc. to Present at Annual BIO CEO & Investor Conference

ˆTop

2003
12/10/03 StemCells Raises $9.5 Million in New Financing.
12/09/03 StemCells, Inc. retains accounting firm Grant Thornton as new independant auditor.
11/17/03 StemCells Inc. Announces Key Research and Development Appointments
11/11/03 StemCells, Inc. Announces Conversion of Convertible Preferred Stock and Receipt of $1.6 Million from Warrant Exercise
11/07/03 StemCells Inc. Preclinical Data Offers Hope for Multiple Sclerosis and Spinal Cord Injury
10/22/03 StemCells reports Financial Results for third quarter of 2003
10/14/03 StemCells, Inc. to Present at Fifth Annual Rodman & Renshaw TechVest Healthcare Conference
09/17/03 StemCells Grants License to StemCell Technologies, Inc., a Canadian company, for Research Use of Murine Neural Stem Cells
09/15/03 StemCells, Inc. to Present at Annual UbS Warburg Global Life Sciences Conference
09/08/03 StemCells, Inc. Receives Grant to Continue Development of Human Neural Stem Cells as Treatment for Spinal Cord Injuries
08/05/03 StemCells reports Financial Results for second quarter of 2003. New European Patents Issued
05/16/03 StemCells reports Financial Results for first quarter of 2003.
05/13/03 StemCells to Raise $6.5 Million in a Private Placement.
05/02/03 StemCells Inc. Announces Study Results Using Human Neural Stem Cells as a Treatment for Spinal Cord Injuries.
04/11/03 StemCells, Inc. presents preclinical proof of concept for treatment of batten Disease, a fatal neurological disorder.
04/04/03 StemCells, Inc. receives U.S. Patent for methods of isolating precursors to insulin producing cells.
04/01/03 StemCells Announces Fourth Quarter and Year End 2002 Financial Results
03/31/03 10Q: StemCells INC
02/26/03 StemCells Inc. Presentation at RedChip Partners boston Conference 2003
(Windows Media Player Required, Audio only)
01/08/03 U.S. Patent Office grants StemCells, Inc. 3 neural stem cell patents, including first patent for transplantation of human neural stem cells

ˆTop

2002
12/20/02 StemCells Moves to Nasdaq SmallCap Market
11/14/02 StemCells Announces Third Quarter 2002 Financial Results
11/14/02 10-Q: StemCells INC
11/06/02 StemCells' Human Neural Stem Cells Show Promise in Pilot PreClinical Stroke Study
11/01/02 StemCells Inc. Announces Change in board of Directors
10/15/02 CEO Martin McGlynn to Present at Techvest's 4th Annual Healthcare Conference
09/23/02 StemCells Inc. Initiates Cost Reduction Program Focuses on Development of Neural and Liver Cells
08/02/02 StemCells, Inc. Announces Second Quarter 2002 Financial Results
07/08/02 StemCells Announces Changes in board of Directors
06/28/02 StemCells Grants License to BioWhittaker for Human Neural Stem Cells For Research Use
05/06/02 StemCells Announces First Quarter 2002 Financial Results and Decision to Increase Number of Authorized Shares
03/06/02 StemCells, Inc. Reports Fourth Quarter and Year End 2001 Results
02/05/02 World Stem Cell Research Community to Convene At February 25026 Conference To Assess Scientific and Commercial Opportunities

ˆTop

2001
12/06/01 StemCells Cancels Warrants Issued to Millennium; Raises $5 Million in New Financing
11/08/01 StemCells, Inc. Announces Third Quarter 2001 Financial Results
10/09/01 NIH Awards StemCells, Inc. Grant for Liver Research
10/03/01 StemCells Elects Ricardo Levy to Its board of Directors
08/13/01 StemCells, Inc. Announces Second Quarter 2001 Financial Results
06/22/01 StemCells, Inc Announces Financing Transaction
06/07/01 StemCells, Inc. Announces Issuance of Two Patents; Neural and Pancreas Stem Cell Portfolios Increased
05/11/01 StemCells, Inc. Secures Equity Line Financing of Up to $30,000,000
05/10/01 StemCells, Inc. Announces First Quarter 2001 Financial Results
05/01/01 StemCells, Inc. Places All Remaining Modex Therapeutics Founder's Stock; Shares Sold in Private Placement
04/03/01 StemCells, Inc. Reports Fourth Quarter and Year End 2000 Results
03/01/01 StemCells, Inc. Announces Receipt of NIH Funding
02/26/01 StemCells, Inc. Announces Move to Expanded Facilities, Board Changes
01/10/01 StemCells, Inc. Sells Modex Therapeutics, Ltd. Shares
01/04/01 StemCells, Inc. Names Martin McGlynn New President and Chief Executive Officer; Former Pharmadigm CEO to Lead Executive Management Team Effective January 15, 2001

ˆTop

2000
12/20/00 StemCells, Inc. Announces board Changes, Publication on SelfRenewal and Transplantation of Neural Stem Cells
11/14/00 StemCells, Inc. Reports Third Quarter Financial Results
11/1/00 First Identification of Purified blood Stem Cells as a Source of Mature Liver Cells Published in Nature Medicine
09/22/00 StemCells, Inc. Plans Management Change
08/30/00 StemCells CEO To Address Investors Online At Stem Cells Forum Thursday, 08ust 31
08/15/00 StemCells, Inc. Releases Second Quarter Financial Results
08/07/00 StemCells, Inc. Announces Private Placement
05/24/00 CytoTherapeutics, Inc. Announces Name Change to StemCells, Inc.
05/15/00 CytoTherapeutics Announces First Quarter Financial Results; Shareholder Equity Increases 110%, Current and Total Liabilities 12rease 60%
04/19/00 Scientists at StemCells California, Inc. Report the First Identification of Purified blood Stem Cells as a Source of Mature Liver Cells
04/17/00 CytoTherapeutics Reports Fourth Quarter and Year End 1999 Results
03/16/00 CytoTherapeutics Announces Settlements With Genentech, Rhode Island Partnership for Science and Technology And Industrial Recreational building Authority
01/31/00 CytoTherapeutics Announces Management Changes
01/20/00 CytoTherapeutics Subsidiary StemCells, Inc. Announces First Direct Isolation of Human brain Stem Cells; Scientists At StemCells, Inc. Report breakthrough At Keystone Symposium Today
01/03/00 CytoTherapeutics Sells Encapsulated Cell Technology To Neurotech S.A.

ˆTop

1999
11/02/99 CytoTherapeutics' Researchers First to Directly Isolate Normal Human Neural Stem Cells; Key Step Toward Clinical Application of Proprietary Stem Cell Technology
10/05/99 CytoTherapeutics' Proprietary Stem Cell Technology Featured in Documentary Program Produced in England
08/16/99 CytoTherapeutics Reports Second Quarter Results
08/02/99 CytoTherapeutics' Study in Experimental Neurology Demonstrates Proprietary Methods for Human Neural Stem/Progenitor Cell Lines
07/23/99 Donald Kennedy Joins board At CytoTherapeutics; Former FDA Commissioner and President Emeritus of Stanford University
07/15/99 CytoTherapeutics' Study in the Journal of Neuroscience Demonstrates Successful Transplantation of Human Neural Stem/Progenitor Cells in Preclinical Model
07/09/99 CytoTherapeutics Restructures to Pursue Development of Its Proprietary Stem Cell Technology Platform
06/24/99 CytoTherapeutics Announces Results From Pain Control Implant Phase II Efficacy Study; Collaboration to Commercialize Encapsulated bovine Cell Therapy for Pain Ends
05/13/99 CytoTherapeutics Reports First Quarter Results
04/28/99 Patrick Aebischer Resigns From CytoTherapeutics' board
02/18/99 CytoTherapeutics Reports 1998 YearEnd Financial Results

ˆTop

1998
12/22/98 U.S. Patent Office Issues CytoTherapeutics' Human Neural Stem Cell Patent; Used To Develop Treatments For Central Nervous System Disorders
12/21/98 CytoTherapeutics Obtains Exclusive, Worldwide Licenses To Technology For Discovering Pancreatic Stem/Progenitor Cells
11/09/98 CytoTherapeutics' Patent Allowed For Encapsulated Cell Delivery Of Therapeutics To Treat The Eye
11/06/98 CytoTherapeutics Researchers Demonstrate Potential For Human Neural Stem Cells To Repair Or Replace CNS Tissue
10/30/98 CytoTherapeutics Reports Third Quarter Results
08/03/98 CytoTherapeutics Reports Second Quarter Results
07/31/98 CytoTherapeutics, Inc. Adopts Shareholder Rights Plan
07/24/98 York Resigns As Executive Vice President Of CytoTherapeutics' Ophthalmics Program
06/15/98 CytoTherapeutics And Astra Resume Phase IIb Clinical Trial Of Pain Control Implant
05/27/98 CytoTherapeutics Genentech Pact Ends
05/04/98 CytoTherapeutics Reports First Quarter Results
04/23/98 CytoTherapeutics Appoints Billie M. York Executive Vice President Of Opthalmics
04/09/98 CytoTherapeutics Restructures board Of Directors
01/15/98 CytoTherapeutics Reports On Status Of Clinical Trials

ˆTop

1997
09/26/97 CytoTherapeutics Acquires StemCells, Inc.
07/28/97 CytoTherapeutics Reports Second Quarter Results
05/06/97 CytoTherapeutics Reports First Quarter Results

ˆTop

1996
11/01/96 CytoTherapeutics Reports Third Quarter Results
07/30/96 CytoTherapeutics Reports Second Quarter Results
05/21/96 Peter K. Simon Joins board At CytoTherapeutics
04/24/96 CytoTherapeutics Reports First Quarter Results
02/05/96 Patrick Aebischer M.D., Ph.D. Joins board At CytoTherapeutics
01/22/96 CytoTherapeutics Reports Year - End Results

ˆTop
© 2000-2010 StemCells, Incorporated, World Rights Reserved. Tel: (650) 475-3100